The World Health Organization (WHO) emphasizes
and provides global guidance for the equitable
deployment of COVID-19 medical products,
including diagnostics, vaccines and therapeutics
(DVT) and personal protective equipment (PPE).
At the national level, Ministry of Health guidelines
list the recommended DVT and PPE for prevention,
diagnosis and management of COVID-19 in Uganda.
Over the past decade, Uganda has increased financial investments in family planning (FP) and restructured
the commodity supply chain as part of broader FP programming reforms that have enabled the country
make progress on the FP2020 goals. In the light of this progress, HEPS-Uganda undertook an assessment
of the country’s FP financing and supply chain landscape and, in this brief, argues that progress on the
country’s FP2020 targets can be accelerated by establishing a separate contraceptives budget-line;
revitalizing social marketing and the private sector; expediting commodity procurements; advocating for
an FP-inclusive National Health Insurance Scheme (NHIS); and improving demand forecasting.
FP commodities for use in the public sector are included in the Uganda Clinical
Guidelines (UCG) and the Essential Medicines and Health Supplies (EMHS) List
of Uganda. These commodities also must be registered by the National Drug
Authority (NDA). The Ministry of Health’s National RMNCAH Quantification Report
guides GOU and partners on the quantities of commodities required and when to
procure them. Guided by the Supply Plans in the quantification report, GOU and
Health Development Partners (HDPs) make financial commitments and initiate the
procurements of the commodities.
This is the third edition of The People’s Voice; the first was published in 2019 and the second in 2020. This People’s Voice on COP21 focuses on the following critical themes: effective management of COVID-19, It also focuses on the promotion of quality, evidence-based, and human rights prevention interventions; expanding biomedical and structural prevention interventions for women and girls including GBV, economic empowerment, and human rights; support for people with disabilities; closing gaps in diagnosis and treatment of children with HIV.
Uganda has an estimated 1,392,742 people living with HIV (PLHIV), consisting of 1,296,000 adults aged 15-64 years (6.2% prevalence) and 96742 children aged 0-14 years (0.5% prevalence). Prevalence is higher among women (7.6%) than among men(4.7%) and among young people (15-24 years), prevalence is four times higher among adolescent girls and young women (3.3%) than among adolescent boys and young men(0.8%). New infections are estimated at 80,500 people per year; 73,000 adults and 7,500 children. Approximately 83% of HIV-positive Ugandans currently access HIV treatment. Despite important progress made by the country towards the national target of reaching epidemic control, Uganda continues to face major challenges that are weakening the impact of the national response.
This is the "People’s Voice 2019" containing Uganda's community priorities and recommendations for PEPFAR for the Country Operational Plan 2019. The recommendations have been developed by people living with HIV and health activists using information gathered in February 2019 during community consultations and additionally through facility monitoring carried out at seven PEPFAR supported sited in four high burden districts including Mbale(Mbale Regional Referral Hospital and TASO Mbale), Lira(Lira Regional Referral Hospital and Amach HCIV), Jinja (Walukuba HCIV and JIACOFE), and Tororo (Mukuju HCIV)
More than 40 civil society organizations led by ICWEA, HEPS – Uganda, Sexual Minorities Uganda have launched the 2021 edition of “The People’s Voice,” a set of ambitious recommendations describing shifts the U.S.
Communities can play a catalytic role in improving health outcomes, service delivery, and overall quality of life and understanding of health within communities. The involvement of recipients of care—and other affected communities—in monitoring their health systems is essential. PEPFAR recognizes the importance of engaging communities in the development and implementation of its programming. As PEPFAR continues to confront the challenges of assuring retention on life-long ART in PLHIV who may not view themselves as sick, collaboration with communities and PLHIV is urgent and critical. This collaboration can help PEPFAR programs and facilities ensure they are providing quality services that beneficiaries want to utilize. Collaboration with community groups, CSOs and PLHIV or beneficiaries can help PEPFAR programs and health institutions diagnose and pinpoint persistent problems, challenges and barriers with service uptake at the site and facility level to effective service and client outcomes at the site. Most importantly this collaboration identifies workable solutions to overcome barriers and ensure beneficiaries have access to services. One approach to this kind of collaboration has been variously referred to as Community Led Monitoring (CLM) among others. The Sustainability Index Dashboard and Responsibility Matrix 2019 indicated poor performance, poor quality of services, poor health workers’ attitudes, health and rights violations, and frequent stock-outs and/or shortages of diagnostics and treatment commodities. While HIV treatment and prevention coverage has steadily improved in Uganda, there are persistent shortcomings in the response. These include; high rates of loss to follow up (LTFU), limited uptake of high impact prevention services such as PrEP, high rates of discontinuation from the DREAMS program, limited access to ‘friendly’ services for HIV positive and HIV negative adolescents/youth, high rates of stigma and discrimination, poor provision of prevention and treatment services for KPs, low community/service recipients’ participation in planning, monitoring and evaluation. Additionally, there is very poor viral load suppression among some groups (paediatrics, pregnant women adolescents, men > 25). As well community and social factors such as stigma, gender and sexuality discrimination, and other social barriers exist. PEPFAR and its IPs have made great progress to realize over 1.2 million on treatment and over 75% virally suppressed. However, there is still need to find the remaining 150,000 HIV infected individuals, link them to treatment and retain all those PLHIV on ART. There is also need to avert new infections especially among risk populations.